BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29948403)

  • 1. Mortality after contralateral breast cancer in Denmark.
    Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
    Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
    Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
    Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
    Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
    Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands.
    Font-Gonzalez A; Liu L; Voogd AC; Schmidt MK; Roukema JA; Coebergh JW; de Vries E; Soerjomataram I
    Breast Cancer Res Treat; 2013 Jun; 139(3):811-9. PubMed ID: 23760860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.
    Liederbach E; Wang CH; Lutfi W; Kantor O; Pesce C; Winchester DJ; Yao K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S412-21. PubMed ID: 26334294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.
    Vichapat V; Garmo H; Holmqvist M; Liljegren G; Wärnberg F; Lambe M; Fornander T; Adolfsson J; Lüchtenborg M; Holmberg L
    J Clin Oncol; 2012 Oct; 30(28):3478-85. PubMed ID: 22927521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contralateral breast cancer: clinical characteristics and impact on prognosis.
    Healey EA; Cook EF; Orav EJ; Schnitt SJ; Connolly JL; Harris JR
    J Clin Oncol; 1993 Aug; 11(8):1545-52. PubMed ID: 8336193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
    Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
    Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
    Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
    Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
    Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
    Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive history and risk of second primary breast cancer: the WECARE study.
    Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for contralateral breast cancer in Chennai (Madras), India.
    Gajalakshmi CK; Shanta V; Hakama M
    Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonaspirin NSAIDs and contralateral breast cancer risk.
    Bens A; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Friis S; Mellemkjaer L
    Int J Cancer; 2019 Mar; 144(6):1243-1250. PubMed ID: 30362513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival from contralateral breast cancer.
    Gajalakshmi CK; Shanta V; Hakama M
    Breast Cancer Res Treat; 1999 Nov; 58(2):115-22. PubMed ID: 10674875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of metachronous contralateral breast cancer in Denmark 1978-2009.
    Rasmussen CB; Kjær SK; Ejlertsen B; Andersson M; Jensen MB; Christensen J; Langballe R; Mellemkjær L
    Int J Epidemiol; 2014 Dec; 43(6):1855-64. PubMed ID: 25326461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
    Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
    Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
    Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
    BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
    Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.